India to Pakistan: Vaccine Export Trade Route
India has recorded 334 verified shipments of Vaccine exported to Pakistan, representing a combined trade value of $88.1M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $263.7K USD. The leading Indian exporter is BIOLOGICAL E. LIMITED, which accounts for 35% of total export value with 112 shipments worth $31.1M USD. On the buying side, EXPANDED PROGRAM ON IMMUNIZATION is the largest importer in Pakistan with $30.9M USD in purchases. The top 3 suppliers — BIOLOGICAL E. LIMITED, BHARAT BIOTECH INTERNATIONAL LIMITED, BIOLOGICAL E LIMITED — together control 69% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Pakistan Vaccine corridor is one of India's established pharmaceutical export routes, with 334 shipments documented worth a combined $88.1M USD. The route is dominated by BIOLOGICAL E. LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $263.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with vaccine's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 29.8%, placing it at rank #10 among India's top vaccine export destinations globally.
On the import side, key buyers of Indian vaccine in Pakistan include EXPANDED PROGRAM ON IMMUNIZATION, EXPANDED PROGRAMME ON IMMUNIZATION, FEDERAL EXPANDED PROGRAMME ON and 79 others. EXPANDED PROGRAM ON IMMUNIZATION is the single largest importer with 42 shipments valued at $30.9M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ4
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#10
- Annual growth+29.8%
- Demand growth+24.9%
- Regulatory ease85/100
Top 10 Indian Vaccine Exporters to Pakistan
Showing top 10 of 17 Indian suppliers exporting Vaccine to Pakistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOLOGICAL E. LIMITED Avg $277.6K per shipment | 112 | $31.1M | 35.3% |
| 2 | BHARAT BIOTECH INTERNATIONAL LIMITED Avg $1.0M per shipment | 17 | $17.6M | 20.0% |
| 3 | BIOLOGICAL E LIMITED Avg $221.8K per shipment | 55 | $12.2M | 13.9% |
| 4 | BIOLOGICAL E. LIMITED Avg $296.3K per shipment | 40 | $11.9M | 13.5% |
| 5 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED Avg $118.2K per shipment | 36 | $4.3M | 4.8% |
| 6 | PANACEA BIOTEC LIMITED Avg $402.4K per shipment | 10 | $4.0M | 4.6% |
| 7 | PANACEA BIOTEC LIMITED Avg $306.3K per shipment | 11 | $3.4M | 3.8% |
| 8 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED Avg $129.9K per shipment | 12 | $1.6M | 1.8% |
| 9 | ZYDUS LIFESCIENCES LIMITED Avg $65.5K per shipment | 13 | $851.7K | 1.0% |
| 10 | INDIAN IMMUNOLOGICALS LIMITED Avg $200.3K per shipment | 2 | $400.5K | 0.5% |
This table shows the top 10 of 17 Indian companies exporting vaccine to Pakistan, ranked by total trade value. The listed exporters are: BIOLOGICAL E. LIMITED, BHARAT BIOTECH INTERNATIONAL LIMITED, BIOLOGICAL E LIMITED, BIOLOGICAL E. LIMITED , SERUM INSTITUTE OF INDIA PRIVATE LIMITED, PANACEA BIOTEC LIMITED, PANACEA BIOTEC LIMITED , SERUM INSTITUTE OF INDIA PRIVATE LIMITED , ZYDUS LIFESCIENCES LIMITED, INDIAN IMMUNOLOGICALS LIMITED . BIOLOGICAL E. LIMITED is the dominant supplier with 112 shipments worth $31.1M USD, giving it a 35% market share. The top 3 suppliers together account for 69% of the total trade value on this route.
Showing top 10 of 17 total Indian exporters on the India to Pakistan Vaccine export route.
Top 10 Vaccine Importers in Pakistan
Showing top 10 of 82 known buyers in Pakistan receiving Vaccine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian vaccine in Pakistan include EXPANDED PROGRAM ON IMMUNIZATION, EXPANDED PROGRAMME ON IMMUNIZATION, FEDERAL EXPANDED PROGRAMME ON , EXPANDED PROGRAMME ON IMMUNIZATION , AMSON VACCINES AND PHARMA PRIVATE LIMITED, among 82 total buyers. The largest importer is EXPANDED PROGRAM ON IMMUNIZATION, accounting for $30.9M USD across 42 shipments — representing 35% of all vaccine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EXPANDED PROGRAM ON IMMUNIZATION | 42 | $30.9M | 35.1% |
| 2 | EXPANDED PROGRAMME ON IMMUNIZATION | 35 | $9.9M | 11.2% |
| 3 | FEDERAL EXPANDED PROGRAMME ON | 16 | $4.5M | 5.2% |
| 4 | EXPANDED PROGRAMME ON IMMUNIZATION | 10 | $4.1M | 4.7% |
| 5 | AMSON VACCINES AND PHARMA PRIVATE LIMITED | 26 | $3.7M | 4.2% |
| 6 | AMSON VACCINES AND PHARMA PVT LTD., | 14 | $3.6M | 4.1% |
| 7 | EXPANDED PROGRAM ON IMMUNIZATION MINISTRY | 2 | $3.0M | 3.4% |
| 8 | EXPANDED PROGRAM ON IMMUNIZATION | 6 | $2.5M | 2.8% |
| 9 | EXPANDED PROGRAM ON IMMUNIZATION E | 4 | $2.4M | 2.7% |
| 10 | ASKARI BANK LTD | 9 | $1.6M | 1.9% |
Showing top 10 of 82 Vaccine importers in Pakistan on this route.
Top 10 Vaccine Formulations Imported by Pakistan
Showing top 10 of 146 product formulations shipped on the India to Pakistan Vaccine route, ranked by trade value
Pakistan imports a wide range of vaccine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE)VLS — accounts for $7.0M USD across 9 shipments. There are 146 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE)VLS | 9 | $7.0M | 7.9% |
| 2 | DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY | 19 | $6.1M | 7.0% |
| 3 | MR VACCINE MEASLES AND RUBELLA VACCINE COMBINED VIAL OF 5 DOSES WITH DILUENT. WITH VACCINE VIAL MONITOR (VVM) | 6 | $5.7M | 6.5% |
| 4 | TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE) | 4 | $5.5M | 6.3% |
| 5 | TYPHOID CONJUGATE VACCINE MONOVALENT 5 DOSE 2.5ML VIAL WITH VACCINE VIAL MONITOR(VVM) | 5 | $4.6M | 5.2% |
| 6 | DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-H | 7 | $3.5M | 4.0% |
| 7 | EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA | 11 | $3.4M | 3.8% |
| 8 | EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA | 5 | $3.0M | 3.4% |
| 9 | TYPBAR TCV-2.5 ML VIAL TYPHOID VI CONJUGATE VACCINE | 2 | $3.0M | 3.4% |
| 10 | S359348 MR VACCINE MEASLES AND RUBELLA | 4 | $2.9M | 3.3% |
Showing top 10 of 146 Vaccine formulations imported by Pakistan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 94 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's vaccine exports to Pakistan are driven primarily by a handful of large-scale manufacturers. BIOLOGICAL E. LIMITED with 112 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BIOLOGICAL E. LIMITED, BHARAT BIOTECH INTERNATIONAL LIMITED, BIOLOGICAL E LIMITED — together account for 69% of total trade value on this route. The average shipment value of $263.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as dtp-hepb-hib (pentavalent vaccine) fully and mr vaccine measles and rubella vaccine combined vial of 5 doses with diluent. with vaccine vial monitor (vvm), suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EXPANDED PROGRAM ON IMMUNIZATION is the largest importer with 42 shipments worth $30.9M USD — representing 35% of all vaccine imports from India on this route. A total of 82 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $88.1M
- Avg. Shipment
- $263.7K
- Suppliers
- 17
- Buyers
- 82
- Transit (Sea)
- ~17 days
- Annual Growth
- +29.8%
Other Vaccine Routes
Unlock the Full India to Pakistan Vaccine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 334 shipments on this route.
Frequently Asked Questions — India to Pakistan Vaccine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Vaccine to Pakistan?
The leading Indian exporters of Vaccine to Pakistan are BIOLOGICAL E. LIMITED, BHARAT BIOTECH INTERNATIONAL LIMITED, BIOLOGICAL E LIMITED. BIOLOGICAL E. LIMITED holds the largest market share at approximately 35% of total trade value on this route.
Q What is the total value of Vaccine exports from India to Pakistan?
India exports Vaccine to Pakistan worth approximately $88.1M USD across 334 recorded shipments. The average value per shipment is $263.7K USD.
Q Which ports does India use to ship Vaccine to Pakistan?
The most active port of origin is HYDERABAD AIR with 94 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Pakistan for Vaccine?
The average transit time for Vaccine shipments from India to Pakistan is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Pakistan Vaccine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.8% with demand growth tracking at 24.9%. The route is ranked #10 among India's top Vaccine export destinations globally.
Q How many suppliers are active on the India to Pakistan Vaccine route?
There are currently 17 active Indian suppliers exporting Vaccine to Pakistan. The market is moderately concentrated with BIOLOGICAL E. LIMITED accounting for 35% of total shipment value.
Q Who are the main importers of Vaccine from India in Pakistan?
The leading importers of Indian Vaccine in Pakistan include EXPANDED PROGRAM ON IMMUNIZATION, EXPANDED PROGRAMME ON IMMUNIZATION, FEDERAL EXPANDED PROGRAMME ON , EXPANDED PROGRAMME ON IMMUNIZATION , AMSON VACCINES AND PHARMA PRIVATE LIMITED. EXPANDED PROGRAM ON IMMUNIZATION is the largest buyer with 42 shipments worth $30.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Pakistan export trade corridor identified from Indian Customs (DGFT) records for Vaccine.
- 2.Supplier/Buyer Matching: 17 Indian exporters and 82 importers in Pakistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 334 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
334 Verified Shipments
17 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists